NCT06178809View on ClinicalTrials.gov

Clinical Research on Dynamic Monitoring MRD Via Plasma ctDNA After Systemic Therapy of Hepatocellular Carcinoma

RecruitingOBSERVATIONAL

Enrollment

475

Participants

Timeline

Start Date

December 25, 2023

Primary Completion Date

April 30, 2025

Study Completion Date

December 31, 2025

Conditions

Hepatocellular Carcinoma

Trial Locations (1)

200032

RECRUITING

Fudan university Zhongshan Hospital, Shanghai

All Listed Sponsors

collaborator

Shanghai Zhongshan Hospital

OTHER

lead

Singlera Genomics Inc.

INDUSTRY